mecamylamine has been researched along with Acute Hypercapnic Respiratory Failure in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Z | 1 |
| Bai, X | 1 |
| Du, K | 1 |
| Huang, Y | 1 |
| Wang, W | 1 |
| Zhao, Y | 1 |
| Pei, Y | 1 |
| Mu, J | 1 |
| Han, H | 1 |
| Hu, S | 1 |
| Li, S | 1 |
| Dong, H | 1 |
| Lu, Y | 1 |
| Hou, L | 1 |
| Xiong, L | 1 |
1 other study available for mecamylamine and Acute Hypercapnic Respiratory Failure
| Article | Year |
|---|---|
Activation of cholinergic anti-inflammatory pathway contributes to the protective effects of 100% oxygen inhalation on zymosan-induced generalized inflammation in mice.
Topics: Aconitine; Animals; Cytokines; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Lung; Mal | 2012 |